It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Objective: To evaluate the doubling rate of maternal serum serial beta human chorionic gonadotropin (β-hCG) and a single initial serum progesterone level to predict fetal viability before ultrasonography in women diagnosed with intrauterine pregnancy (IUP) of undetectable viability.
Methods: Three hundred thirty six pregnant women who applied to the outpatient Clinic at Okmeydanı Hospital between March and December 2018 were evaluated on a “prospective observational” basis. The study was completed with 100 pregnant women diagnosed with IUP involving suspected fetal viability by transvaginal ultrasonography only, who met the inclusion criteria. Serum β-hCG and progesterone levels were measured at the first admission. After 48 h, control serum β-hCG was taken and the increase rates were calculated. Early pregnancy loss was diagnosed by (transvaginal) TV-USG. Patients were divided into two groups as fetal heartbeat (FHB) positive and FHB negative. Pregnancy results were compared with β-hCG increase rates and progesterone levels.
Results: No statistically significant result was obtained between FHB +/- groups in terms of maternal age, previous pregnancy anamnesis, nationality, presenting symptoms, or ultrasound findings. The study, which was conducted with a confidence interval of 95%, found the viability rate to be 70% with a β-hCG increase rate of 31% and 100% in the case of an increase of 181%. For progesterone, when the value was 5.9 ng/mL, the viability rate was 49% and 100% at 37.5 ng/mL and above. The efficacy values of β-hCG increase and first progesterone level in predicting viability were found to be ROC AUC: [0.748 (0.621-0.874)] and ROC AUC: [0.796 (0.685-0.907)], respectively.
Conclusion: Either Serial β-hCG ratio or serum progesterone level can be used alone to predict the pregnancy outcome in early pregnancy. With the dissemination of similar studies, estimation modalities can be improved, and TV-USG examinations can help shorten the waiting time for results to reduce the anxiety of families, hospital admissions and health expenses.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer